Daniel Grunder

Vorsitzender bei

GoodWind Holding GmbH

Consumer Durables

Finance

Health Technology

Profil

Daniel Grunder is associated with GoodWind Holding GmbH, Welle Holding AG + Co. KG, and TXP Pharma AG (Switzerland) as a Chairman, Director, and Director respectively.

Aktive Positionen von Daniel Grunder

Unternehmen	Position	Beginn
Welle Holding AG + Co. KG Welle Holding AG + Co. KG Home FurnishingsConsumer Durables Operates as a financial holding company whose subsidiaries manufactures ready to-assemble bedroom and kitchen furniture	Direktor/Vorstandsmitglied	-
TXP Pharma AG (Switzerland) TXP Pharma AG (Switzerland) Pharmaceuticals: MajorHealth Technology Engages in researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases	Direktor/Vorstandsmitglied	-
GoodWind Holding GmbH GoodWind Holding GmbH Financial ConglomeratesFinance Engages in the acquisition, management and sale of securities and similar assets, handling of financing & fiduciary transactions	Vorsitzender	-

Alle aktiven Positionen von Daniel Grunder

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Daniel Grunder im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	3
Welle Holding AG + Co. KG Welle Holding AG + Co. KG Home FurnishingsConsumer Durables Operates as a financial holding company whose subsidiaries manufactures ready to-assemble bedroom and kitchen furniture	Consumer Durables
GoodWind Holding GmbH GoodWind Holding GmbH Financial ConglomeratesFinance Engages in the acquisition, management and sale of securities and similar assets, handling of financing & fiduciary transactions	Finance
TXP Pharma AG (Switzerland) TXP Pharma AG (Switzerland) Pharmaceuticals: MajorHealth Technology Engages in researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases	Health Technology